EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
- Healthcare providers in India are leveraging GenAI for workforce efficiency, predictive analysis, clinical decision support and supply chain management
- GenAI is expected to boost productivity by 30%-32% by 2030, largely driven by non-clinical operations, clinical operations in addition to sales, branding and community outreach
- Despite challenges like data sensitivity and legacy systems, GenAI is poised to revolutionize India’s healthcare sector, driving productivity and improving patient outcomes
Global leaders in AI and healthcare are driving innovative projects that highlight the transformative power of GenAI. Healthcare providers worldwide are embracing GenAI to improve patient care, optimize operations and foster innovation. From personalized treatment plans and automated diagnostics to virtual health assistants and drug discovery, GenAI is reshaping traditional healthcare models and enhancing outcomes across the industry. GenAI adoption in India’s healthcare sector is accelerating as providers modernize their systems, enhance diagnostics, and boost operational efficiency. It is being used to tackle critical challenges like increasing diagnostic precision, advancing telemedicine, and extending healthcare access in rural areas.
GenAI impact on productivity across healthcare value chain
View the full EY AIdea 2025 report
Navigate your AI journey
Get in touch with us to learn more about EY.ai, a holistic approach to AI.